A clinical trial considered the "gold standard" for clinical investigation has concluded that "no benefit" of hydroxychloroquine was found on patients hospitalised with the coronavirus, researchers said on Friday.

Major trial says 'no benefit' of Trump-backed hydroxychloroquine

As US President Donald Trump continues to back the anti-malarial drug hydroxychloroquine as a potential treatment to novel coronavirus, a new study has claimed that the drug does not avoid infection in a statistically meaningful way.

New study says Trump-backed hydroxychloroquine no better than placebo

coronavirus-hydroxychloroquine

Coronavirus Hydroxychloroquine, News on Coronavirus Hydroxychloroquine, stories on Coronavirus Hydroxychloroquine, articles on Coronavirus Hydroxychloroquine, Coronavirus Hydroxychloroquine stories at Wion, Coronavirus Hydroxychloroquine news, Coronavirus Hydroxychloroquine latest news

coronavirus hydroxychloroquine

Major trial says 'no benefit' of Trump-backed hydroxychloroquine

New study says Trump-backed hydroxychloroquine no better than placebo